bi-1810631
boehringer ingelheim
['lung', 'bi1810631 ']
#asco22 june 6, 8 am ct, hall a, poster 126a: lcrf scientific advisory board member dr. john heymach will present a poster session on a phase 1 trial of bi1810631 as monotherapy for #lungcancer tumors with her2 aberrations. 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.